The pet medication manufacturers industry in the DACH region focuses on providing health solutions for pets through pharmaceuticals, supplements, and innovative treatment methods. Companies in this industry range from large food and beverage corporations, like Nestlé, to specialized health-focused startups. Growing awareness of pet health and wellness among pet owners drives market demand, pushing businesses to develop effective medications and health products tailored for pets. With advancements in technology and biotechnology, the industry is poised for growth, exploring novel therapies and digital healthcare solutions that enhance pet care while promoting well-being in the trusted role of human companions.


The list features a mix of investors primarily from the corporate and venture capital sectors, with headquarters in Switzerland and Germany. Their sizes range from small firms to large corporate investors, each exhibiting distinct focuses and investment strategies. Founded between 1866 and 2021, these firms have collectively undertaken numerous deals in 2024, signaling a robust interest in the evolving pet medication sector. Notable mentions include Nestlé and the Boehringer Ingelheim Venture Fund, showcasing the blend of established corporate players and agile venture capital firms eagerly investing in innovative health solutions for pets.


Top 11 Pet Medication Manufacturers Investors in DACH


1. Nestlé

  • Website: nestle.com
  • Type: Corporate
  • Headquarters: Vevey, Vaud, Switzerland
  • Founded year: 1866
  • Headcount: 10001+
  • Number of deals in 2024: 2
  • LinkedIn: nestle-s-a-

Nestlé S.A. is a multinational food and beverage company based in Vevey, Vaud, Switzerland, founded in 1866. With over 10,000 employees, Nestlé offers a diverse range of products, including coffee, dairy, and pet care items. The company is committed to sustainability and operates globally, serving both consumers and businesses. Notably, Nestlé has made significant investments in the pet care sector, including the acquisition of Ralston Purina Company in 2001, which is a major player in pet food and care. In 2010, Nestlé further expanded its pet care portfolio by acquiring Waggin' Train, a brand known for its pet treats. These transactions highlight Nestlé's strategic focus on the pet care market, which includes potential overlaps with pet medication manufacturers.


2. Boehringer Ingelheim Venture Fund

  • Website: boehringer-ingelheim-venture.com
  • Type: Venture Capital
  • Headquarters: Ingelheim Am Rhein, Rhineland-Palatinate, Germany
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 5

Boehringer Ingelheim Venture Fund is a venture capital firm founded in 2010, based in Ingelheim Am Rhein, Germany. The fund focuses on pioneering science and biotechnology innovations, particularly in the healthcare sector. It provides capital and expertise to startups, helping them develop and commercialize their products. Notably, the fund has participated in significant transactions, including a funding round for Ruipeng Pet Healthcare, which raised hundreds of millions of dollars and is valued at nearly $4.4 billion. This investment underscores the fund's interest in the pet healthcare market. Additionally, the fund has been involved in other healthcare-related investments, but its participation in pet healthcare initiatives positions it as a relevant player in the pet medication manufacturers industry.


3. Nestlé Health Science


Nestlé Health Science is a health and nutrition company founded in 2011, based in Lausanne, Vaud, Switzerland. It specializes in medical nutrition, active lifestyle nutrition, and pharmaceuticals, offering a diverse range of products aimed at improving health outcomes for patients and consumers. The company serves various customer segments, including healthcare professionals and individuals seeking nutritional support. Notably, Nestlé Health Science has made significant investments in the pet healthcare sector, including a private equity round for Ruipeng Pet Healthcare, which highlights its interest in the pet medication market. This investment reflects the company's strategy to expand its portfolio into pet health, complementing its broader focus on science-based nutritional solutions. Additionally, Nestlé Health Science has been involved in various other transactions, such as acquiring Prometheus Biosciences and Aimmune Therapeutics, which, while not directly related to pet medication, showcase its active investment strategy in health-related sectors.


4. Partners Group

  • Website: partnersgroup.com
  • Type: Private Equity
  • Headquarters: Baar, Zug, Switzerland
  • Founded year: 1996
  • Headcount: 1001-5000
  • Number of deals in 2024: 19
  • LinkedIn: partners-group

Partners Group Holding AG is a prominent investment management firm based in Baar, Zug, Switzerland, specializing in private equity, private infrastructure, private real estate, and private debt. Founded in 1996, the firm manages over USD 149 billion in assets and is recognized for its innovative investment strategies and commitment to sustainability. Among its notable transactions, Partners Group has acquired Wedgewood Pharmacy, a key player in the pet medication sector, highlighting their involvement in the intersection of pet care and healthcare. Additionally, their acquisition of Blue River PetCare for over $440 million further underscores their focus on the pet care industry. These strategic investments reflect Partners Group's dedication to expanding its portfolio in sectors that include pet medication, making them a relevant investor in this field.


5. redalpine


Redalpine is a venture capital firm based in Zurich, Switzerland, founded in 2006. The firm specializes in investing in technology and science sectors, providing funding and strategic support to startups, particularly in areas like AI, health tech, and energy. Notably, Redalpine has invested in Felmo, a Berlin-based pet health startup, participating in both Series A and Series B funding rounds, which raised significant capital to expand their e-commerce offerings and operations. This involvement highlights Redalpine's commitment to supporting innovative solutions in the pet health space, making them a relevant player in the pet medication manufacturers industry.


6. IBB Ventures


IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in early-stage financing and has invested in over 270 startups, providing not only funding but also expertise and resources to help these businesses thrive. Among their notable transactions, IBB Ventures has invested in vetevo, a company that raised funds in seed rounds in 2018 and 2019, focusing on pet health solutions. This investment highlights IBB Ventures' engagement in the pet medication sector, showcasing their commitment to supporting innovative startups in this industry.


7. Point Nine

  • Website: pointnine.com
  • Type: Venture Capital
  • Headquarters: Berlin, Berlin, Germany
  • Founded year: 2011
  • Headcount: 11-50
  • Number of deals in 2024: 16
  • LinkedIn: point-nine-capital

Point Nine is a Berlin-based venture capital firm founded in 2011, specializing in early-stage investments, particularly in the SaaS, enterprise software, and B2B marketplace sectors. They provide seed funding and participate in subsequent funding rounds to help startups scale their operations. Notably, Point Nine has invested in several companies within the pet industry, including Alphapet Ventures and Hundeland.de, which focus on pet products and services. Additionally, they led a $4.4 million seed round for PetsApp, a client engagement platform for pet services. These transactions highlight Point Nine's engagement in the pet sector, indicating their potential interest in pet medication manufacturers.


8. Green Generation Fund


Green Generation Fund is a venture capital firm based in Berlin, Germany, founded in 2021. The firm specializes in early-stage investments in Food Tech and Green Tech startups, aiming to drive significant positive impacts in sustainability by supporting innovative solutions that address climate change and resource challenges. In 2022, Green Generation Fund led a €3.5 million Series A funding round for VEGDOG, a Munich-based PetTech startup that focuses on creating sustainable, plant-based diets for pets. This investment highlights their commitment to the pet industry and aligns with their mission to support sustainable practices. Additionally, the firm has been involved in various other sectors, but their engagement with VEGDOG positions them as a relevant player in the pet care market.


9. Thia Ventures

  • Website: thiaventures.com
  • Type: Venture Capital
  • Headquarters: Plan-Les-Ouates, Geneva, Switzerland
  • Founded year: 2021
  • Headcount: 1-10
  • Number of deals in 2024: 3
  • LinkedIn: thia-ventures

Thia Ventures is a venture capital firm based in Plan-Les-Ouates, Geneva, Switzerland, founded in 2021. The firm focuses on investing in early-stage companies at the intersection of food, biotech, and health. Thia Ventures provides funding and support to innovative startups aiming to transform food systems and improve health outcomes. Their portfolio includes a diverse range of companies specializing in enzyme engineering, cultivated meats, and biofertilizers. Notably, Thia Ventures participated in the Series A funding round for Bond Pet Foods, which raised $17.5 million to expand its meat protein portfolio, indicating their engagement in the pet food sector. This involvement suggests a potential interest in the broader pet health and medication market, aligning with their investment strategy in health-related innovations.


10. Vorwerk Ventures


Vorwerk Ventures is a Berlin-based venture capital fund founded in 2007, specializing in early-stage investments across various sectors, including consumer products, food, health, and climate. The firm provides seed and Series A funding to innovative startups with strong business models and market potential. Notably, Vorwerk Ventures has invested in Rex, a Berlin-based company that raised €5 million for product optimization and marketing, and Dinner for Dogs, which raised funds in 2008. These investments highlight their engagement in the pet industry, particularly in companies that could align with pet medication manufacturing.


11. Project A

  • Website: project-a.com
  • Type: Venture Capital
  • Headquarters: Berlin, Berlin, Germany
  • Founded year: 2012
  • Headcount: 51-200
  • Number of deals in 2024: 13
  • LinkedIn: project-a-ventures

Project A is a venture capital firm based in Berlin, Germany, founded in 2012. They specialize in early-stage tech investments and provide operational support for startups. Their services include consulting in technology and growth, access to a network of investors, and pre-seed investment opportunities. In 2024, Project A has made 13 investments, showcasing their active role in the investment landscape. Notably, they have invested in Pets Deli, a Berlin-based startup focused on pet food, and Dalma, a French pet insurance startup. These investments highlight their engagement in the pet industry, particularly in companies that cater to pet health and wellness, aligning with the interests of pet medication manufacturers.



Pet Medication Manufacturers Insights: Key Investors in DACH


InvestorHeadquarterSizeFoundedDeals 2024
NestléVevey, Vaud, Switzerland10001+18662
Boehringer Ingelheim Venture FundIngelheim Am Rhein, Rhineland-Palatinate, Germany11-5020105
Nestlé Health ScienceLausanne, Vaud, Switzerland10001+20112
Partners GroupBaar, Zug, Switzerland1001-5000199619
redalpineZurich, Zurich, Switzerland11-50200618
IBB VenturesBerlin, Berlin, Germany11-50199718
Point NineBerlin, Berlin, Germany11-50201116
Green Generation FundBerlin, Berlin, Germany1-1020218
Thia VenturesPlan-Les-Ouates, Geneva, Switzerland1-1020213
Vorwerk VenturesBerlin, Berlin, Germany11-5020077
Project ABerlin, Berlin, Germany51-200201213


Want to find more investors focusing on the pet medication manufacturers industry?

If you want to find more investors that are active in the pet medication manufacturersindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!